Clorox (CLX) FY2019 results: revenue $6.2 billion, up 1.5% on the year
Clorox Co. (CLX) reported revenue of $6.2 billion for fiscal 2019, the year ended 30 June 2019, up 1.5% on the year before. Net income was $820 million, down 0.4%, and diluted earnings per share $6.32. The figures are the company's own, from the 10-K it filed with the SEC on 14 August 2019.
Revenue
$6.2 billion
+1.5% on the year
FY2012FY2019
Operating margin
n/a
FY2012FY2019
Net income
$820 million
-0.4% on the year
FY2012FY2019
Diluted EPS
$6.32
+1.0% on the year
FY2012FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
6,214
6,124
5,973
+1.5%
Cost of revenue
3,486
3,449
3,302
+1.1%
Gross profit
2,728
2,675
2,671
+2.0%
Gross margin
43.9%
43.7%
44.7%
Research and development
136
132
135
+3.0%
Selling, general and administrative
856
837
810
+2.3%
Interest expense
97.0
85.0
88.0
+14.1%
Pre-tax income
1,024
1,054
1,033
-2.8%
Income tax
204
231
330
-11.7%
Effective tax rate
19.9%
21.9%
31.9%
Net income
820
823
701
-0.4%
Net margin
13.2%
13.4%
11.7%
Diluted EPS
$6.32
$6.26
$5.33
+1.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
992
976
865
+1.6%
Capital expenditure
206
194
231
+6.2%
Free cash flow
786
782
634
+0.5%
Free cash flow margin
12.6%
12.8%
10.6%
Cash from investing
-196
-859
-205
Cash from financing
-815
-399
-645
Depreciation and amortisation
180
166
163
+8.4%
Share-based compensation
43.0
53.0
51.0
-18.9%
Buybacks
661
271
183
+143.9%
Dividends paid
490
450
412
+8.9%
Dividend per share
$3.94
$3.60
$3.24
+9.4%
Diluted shares, weighted
130m
132m
132m
-1.4%
Shares outstanding at period end
126m
128m
129m
-1.8%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
559
726
542
-23.0%
Debt
2,683
2,483
2,195
+8.1%
Other liabilities
1,874
1,851
1,836
+1.2%
Total liabilities and equity
5,116
5,060
4,573
+1.1%
Fixed assets
1,034
996
931
+3.8%
Goodwill
1,591
1,602
1,196
-0.7%
Intangible assets
912
929
722
-1.8%
Cash and equivalents
111
131
418
-15.3%
Receivables
631
600
565
+5.2%
Inventory
512
506
459
+1.2%
Other assets
325
296
282
+9.8%
Total assets
5,116
5,060
4,573
+1.1%
10-K for the year ended 30 June 2019, filed 14 August 2019: the filing.